Concerned Shareholders of Cano Health Issue Presentation to Underscore the Urgent Need for Changes in Leadership and Strategy Following Massive Value Destruction at the Company

Rhea-AI Summary

Elliot Cooperstone, Lewis Gold, and Barry Sternlicht, who recently resigned from the Board of Directors of Cano Health, Inc., have issued a presentation outlining the case for changes in leadership and strategy at the company. They are urging stockholders to withhold support for Dr. Alan Muney and Kim Rivera, the only directors standing for re-election at the Annual Meeting. The Group holds an approximately 35% equity stake in Cano.

Positive

• The Group holds an approximately 35% equity stake in Cano

Negative

• None.

Details the Ways in Which Dr. Alan Muney, Chair of the Compensation Committee, and Kim Rivera, Chair of the Nominating and Corporate Governance Committee, Have Failed Stockholders

Urges Stockholders to Help Initiate a Turnaround by WITHHOLDING Support for Dr. Muney and Ms. Rivera – the Only Directors Standing for Re-Election at the Annual Meeting

Reiterates Parties are Awaiting a Resolution of Litigation to Compel the Company to Reopen Window for Nominating Director Candidates and Making Proposals

NEW YORK & MIAMI--(BUSINESS WIRE)-- Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group,” “us” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO), today announced that they have issued a presentation that outlines the urgent case for changes in leadership and strategy at the Company. The Group, which holds an approximately 35% equity stake in Cano, is soliciting WITHHOLD votes against the two members of the Board up for re-election at the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) on June 15, 2023: Dr. Alan Muney, Chair of Cano’s Compensation Committee, and Kim Rivera, Chair of Cano’s Nominating and Corporate Governance Committee. Dr. Muney and Ms. Rivera are also members of Cano’s Audit Committee. The Group believes stockholders can take the first step toward turning around Cano by voting WITHHOLD on Proposal 1 (Election of Dr. Muney and Ms. Rivera) on any proxy card received (GREEN or WHITE).

DOWNLOAD AND READ THE GROUP’S PRESENTATION BY CLICKING HERE.

As a reminder, the Group has also submitted a notice to Cano to nominate two highly qualified, independent candidates – Joseph Berardo, Jr. and Guy P. Sansone – for election to the Board at the Annual Meeting. Messrs. Berardo and Sansone possess significant healthcare services experience as well as backgrounds in corporate governance, capital allocation, transactions and strategic planning. The Group also submitted a business proposal to give stockholders the opportunity to vote on the removal of Dr. Marlow Hernandez, the Company’s Chief Executive Officer, from the Board for cause at the Annual Meeting.

Stockholders’ ability to vote on the election of the Group’s director candidates and its other proposal at the Annual Meeting is dependent on the success of its previously disclosed action in the Delaware Court of Chancery. The action seeks to compel Cano to reopen the window for nominating director candidates and making proposals under the Company’s Bylaws at the upcoming Annual Meeting. A ruling is expected in early June.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230530005620/en/

Investors:

HKL & Co., LLC

Peter Harkins, Jr. / Jordan Kovler

Toll-Free: (800) 326-5997

CANO@hklco.com

Media:

Longacre Square Partners

Charlotte Kiaie / Greg Marose, 646-386-0091

ckiaie@longacresquare.com / gmarose@longacresquare.com

Source: InTandem Capital Partners, LLC

FAQ

Who recently resigned from the Board of Directors of Cano Health, Inc?

Elliot Cooperstone, Lewis Gold, and Barry Sternlicht

What is the Group urging stockholders to do?

Withhold support for Dr. Alan Muney and Kim Rivera

What is the Group's equity stake in Cano?

Approximately 35%